48
Participants
Start Date
August 2, 2016
Primary Completion Date
June 30, 2020
Study Completion Date
December 31, 2020
AZD9291
AZD9291, 80 mg (tablets) once daily, administered orally in the fasted state
University Hospital of Patra-Rio, Rio
University Hospital of Heraklion Crete, Heraklion
251 Air Forces Military Hospital of Athens, Athens
"Anticancer Hospital of Athens Agios Savvas", Athens
"Athens Hospital Mitera Hygia Polis", Athens
"General Hospital of Athens Aretaieio", Athens
"General Hospital of Athens Evangelismos", Athens
"General Oncology Hospital of Athens Ag. Anargiroi", Athens
IASO General Hospital, Athens
"Universtiy Hospital of Athens Attikon", Athens
Diabalkaniko General Hospital of Thessaloniki, Thessaloniki
"General Hospital of Thesaloniki G. Papanikolaou", Thessaloniki
Thessaloniki Bioclinic, Thessaloniki
Lead Sponsor
Hellenic Oncology Research Group
OTHER